Use of subcutaneous immunoglobulin in primary immune deficiencies

Creative Commons License

AYDINER E., Kiykim A., BARIŞ S., Ozen A. O., Barlan I.

TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, cilt.51, sa.1, ss.8-14, 2016 (ESCI) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 51 Sayı: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5152/turkpediatriars.2016.3058
  • Dergi Adı: TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.8-14
  • Anahtar Kelimeler: Child, primary immune deficiency, subcutaneous immunoglobulin, PRIMARY ANTIBODY DEFICIENCIES, IGG REPLACEMENT THERAPY, DISEASES, CHILDREN, SAFETY, ADULTS
  • Marmara Üniversitesi Adresli: Evet

Özet

Aim: Immunoglobulin replacement therapy is required to reduce the frequency and severity of infections in patients with primary antibody deficiencies. Immunoglobulin G (IgG) can be administered intramuscularly, intravenously or subcutaneously. We aimed to evaluate the efficacy, dose adjustment and adverse events in subcutaneous immunoglobulin therapy by retrospectively presenting the records of 16 patients who received subcutaneous immunoglobulin therapy.